FIIN-3

CAS No. 1637735-84-2

FIIN-3 ( FIIN3; FIIN 3; FIIN-3 )

Catalog No. M17353 CAS No. 1637735-84-2

FIIN-3 is an irreversible inhibitor of FGFR.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 68 In Stock
5MG 110 In Stock
10MG 178 In Stock
25MG 399 In Stock
50MG 590 In Stock
100MG 840 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FIIN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    FIIN-3 is an irreversible inhibitor of FGFR.
  • Description
    FIIN-3 is a potent, selective, irreversible and the next-generation covalent FGFR inhibitor. FIIN-3 is the first inhibitor that can potently inhibit the proliferation of cells dependent upon the gatekeeper mutants of FGFR1 or FGFR2, which confer resistance to first-generation clinical FGFR inhibitors such as NVP-BGJ398 and AZD4547. FIIN-3 has the unprecedented ability to inhibit both the EGF receptor (EGFR) and FGFR covalently by targeting two distinct cysteine residues. FIIN-3 bound with FGFR4 V550L and EGFR L858R.
  • Synonyms
    FIIN3; FIIN 3; FIIN-3
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    FGFR1; FGFR2; FGFR3; FGFR4
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1637735-84-2
  • Formula Weight
    691.61
  • Molecular Formula
    C34H36Cl2N8O4
  • Purity
    98%
  • Solubility
    DMSO : 10 mg/mL 14.46 mM;
  • SMILES
    C(=O)(C=C)Nc1ccc(cc1)CN(c1ncnc(c1)Nc1ccc(cc1)N1CCN(CC1)C)C(=O)Nc1c(c(cc(c1Cl)OC)OC)Cl
  • Chemical Name
    N-(4-((3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)ureido)methyl)phenyl)acrylamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tan L et al. Proc Natl Acad Sci U S A, 2014 Nov 11, 111(45):E4869-77
molnova catalog
related products
  • SRT 1460

    SRT1460 is a potent, selective SIRT1 activator with EC1.5 of 2.9 uM.

  • JGB1741

    JGB1741 is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer.

  • SirT1 enhancer A03

    SirT1 enhancer A03 is a specific, orally bioavailable, brain penetrant apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer.